About: PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1995 (uk) article scientifique publié en 1995 (fr) im Februar 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1995 (ast) artikull shkencor i botuar më 01 shkurt 1995 (sq) scientific article published on 01 February 1995 (en)
publication date	wds:Q71682339-2E6DD642-5536-41AA-B07D-4638C4C1C634
publication date	1995-02-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71682339-3CAEDA3B-CAFA-4B27-8E27-9BFE17B62BC4 wds:Q71682339-6290E0BC-A07E-41A2-B505-C8B8C21A75AA wds:Q71682339-885113D9-0BD2-4F93-A92F-D05E1808AACF wds:Q71682339-E221E8D4-F2B8-4C07-8BA7-E0BEB5CDDF3D
author name string	L P Chen S M Cai Z T Li J X Fan
rdfs:label	PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (en) PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (nl) PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (sq)
skos:prefLabel	PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (en) PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (nl) PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (sq)
name	PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (en) PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (nl) PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (sq)
title	wds:Q71682339-A073D96E-D027-44A9-9BA3-C4025D818BC2
title	PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma (en)
page(s)	wds:Q71682339-B4ECA099-F16D-4220-914F-A9B0A2FC0FD8
page(s)	231-234
instance of	wds:Q71682339-DABC70BD-82E0-4824-B9FA-F9EC5DAB86FF
instance of	scholarly article
main subject	wds:Q71682339-01C16F23-25C1-4247-B4BB-819B1D52C2C1 wds:Q71682339-79A3E7F2-07FC-4703-9231-E1E06E4EE16D wds:Q71682339-C7921DCB-11A8-444E-833A-CF4FB8542178 wds:Q71682339-CFDF893A-2B46-4405-97E7-A609C8C157E5
main subject	wd:Q18936 choriocarcinoma wd:Q418817 cisplatin
PubMed ID	wds:Q71682339-FD26AAD5-5FA6-4818-A20F-E02F45752C0A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7534740
PubMed ID	7534740
published in	wds:Q71682339-19945E75-2D2A-40C7-BDEF-3BCC2CD63260
published in	Gynecologic Oncology
issue	wds:Q71682339-07D2E2BE-32C0-4F23-9E53-656F9ACFAD78
volume	wds:Q71682339-69B81F17-1225-4BD8-9BB5-07363052D0EF
issue	2
volume	56
DOI	wds:Q71682339-24697B22-7503-4D25-B431-4EEDDA4F842F
DOI	http://dx.doi.org/10.1006/GYNO.1995.1037
DOI	10.1006/GYNO.1995.1037
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71682339
is cites work of	MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol Circulating MiR-125b as a marker predicting chemoresistance in breast cancer Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance Management of primary intracranial germ cell tumors The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer. Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel Treatment of metastatic gestational trophoblastic neoplasia Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future management Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma
is cites work of	wds:Q37545742-A702BC37-B237-48BA-9D91-442228AB65EE wds:Q46748726-1795BEC7-2AC5-44B3-BB82-1D730E58D8EB wds:Q33674156-D7DDFBE0-4F3D-4D06-B3FA-370BC676F4A2 wds:Q33691999-4E39BF3A-F9DB-49C1-A417-3FB081C1E9BD wds:Q33967256-3410D997-8D24-4A80-B78B-824EE5F6B6B9 wds:Q36902449-D0B3B91F-764C-469A-909C-942FBE04CFB4 wds:Q35776971-9B8B7FC2-0F04-42CB-9E6C-687EF078B774 wds:Q41592835-AC366A70-D3D5-4C57-AE8B-BCDEC865629B wds:Q55017551-978437EB-276F-431A-9959-A99F6B42DAE8 wds:Q28482362-C7B412C9-58AF-48F7-81D3-34BED1AE7A48 wds:Q35167498-F7508E44-62FF-4A41-ADD7-5C1D2AA3BA9A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software